FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 138 filers reported holding FLEXION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | +50.0% | 1,963 | +103.8% | 0.00% | – |
| Q2 2021 | $8,000 | -100.0% | 963 | -77.6% | 0.00% | – |
| Q1 2021 | $38,486,000 | +427522.2% | 4,300 | +469.5% | 0.00% | – |
| Q4 2020 | $9,000 | -18.2% | 755 | -28.4% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 1,055 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +75.0% | 1,055 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -61.9% | 1,055 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +50.0% | 1,055 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | +16.7% | 1,055 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -42.9% | 1,055 | -5.1% | 0.00% | -100.0% |
| Q3 2018 | $21,000 | -72.4% | 1,112 | -62.2% | 0.00% | -80.0% |
| Q2 2018 | $76,000 | +38.2% | 2,942 | +19.3% | 0.01% | +25.0% |
| Q1 2018 | $55,000 | -9.8% | 2,467 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $61,000 | +48.8% | 2,467 | +43.0% | 0.01% | +25.0% |
| Q3 2017 | $41,000 | +583.3% | 1,725 | +475.0% | 0.00% | +300.0% |
| Q2 2017 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |